Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages
- PMID: 10947071
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages
Abstract
We evaluated the synthesis of nitric oxide (NO) and of the neurotoxic kynurenine metabolites 3OH-kynurenine and quinolinic acid (QUIN) in interferon-gamma (IFN-gamma)-activated macrophages of the murine BACl.2F5 cell line with the aim of investigating the roles of mononuclear phagocytes in inflammatory neurological disorders. IFN-gamma induced indoleamine 2,3-dioxygenase (IDO) and NO synthase (NOS) and increased the synthesis of 3OH-kynurenine, QUIN, and NO that accumulated in the incubation medium where they reached neurotoxic levels. Macrophage exposure to norharmane, an IDO inhibitor, resulted in a decreased formation of not only the kynurenine metabolites but also NO. The inhibition of NO synthesis could not be ascribed to reduced NADPH availability or decreased NOS induction. Norharmane inhibited NOS activity also in coronary vascular endothelial cells and in isolated aortic rings. Our findings suggest that activated macrophages release large amounts of neurotoxic molecules and that norharmane may represent a prototype compound to study macrophage involvement in inflammatory brain damage.
Similar articles
-
Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.J Immunol. 1997 Jul 1;159(1):419-26. J Immunol. 1997. PMID: 9200481
-
Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism?Arch Biochem Biophys. 1999 Dec 1;372(1):1-7. doi: 10.1006/abbi.1999.1381. Arch Biochem Biophys. 1999. PMID: 10562410
-
Neuronal localization of indoleamine 2,3-dioxygenase in mice.Neurosci Lett. 2005 Oct 21;387(2):95-9. doi: 10.1016/j.neulet.2005.07.010. Neurosci Lett. 2005. PMID: 16076525
-
Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.Ann N Y Acad Sci. 2007 Dec;1122:35-49. doi: 10.1196/annals.1403.003. Ann N Y Acad Sci. 2007. PMID: 18077563 Review.
-
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.Int J Biochem Cell Biol. 2009 Mar;41(3):467-71. doi: 10.1016/j.biocel.2008.01.005. Epub 2008 Jan 11. Int J Biochem Cell Biol. 2009. PMID: 18282734 Review.
Cited by
-
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment.Pharmaceuticals (Basel). 2024 Jul 25;17(8):983. doi: 10.3390/ph17080983. Pharmaceuticals (Basel). 2024. PMID: 39204088 Free PMC article. Review.
-
An integrated cytokine and kynurenine network as the basis of neuroimmune communication.Front Neurosci. 2022 Nov 24;16:1002004. doi: 10.3389/fnins.2022.1002004. eCollection 2022. Front Neurosci. 2022. PMID: 36507331 Free PMC article. Review.
-
Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease.Int J Tryptophan Res. 2022 Oct 29;15:11786469221126063. doi: 10.1177/11786469221126063. eCollection 2022. Int J Tryptophan Res. 2022. PMID: 36329761 Free PMC article.
-
An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase-Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.Front Immunol. 2018 Jun 15;9:1363. doi: 10.3389/fimmu.2018.01363. eCollection 2018. Front Immunol. 2018. PMID: 29963055 Free PMC article. Review.
-
Screening of Norharmane from Seven Cyanobacteria by High-performance Liquid Chromatography.Pharmacogn Mag. 2017 Oct;13(Suppl 3):S723-S725. doi: 10.4103/pm.pm_214_17. Epub 2017 Oct 11. Pharmacogn Mag. 2017. PMID: 29142439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials